Yufei Xiang Selected Research

Latent Autoimmune Diabetes in Adults

3/2016	Altered Peripheral B-Lymphocyte Subsets in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults.
1/2016	HLA Genetic Discrepancy Between Latent Autoimmune Diabetes in Adults and Type 1 Diabetes: LADA China Study No. 6.
1/2016	Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up.
5/2015	[Effects of rare islet autoantibodies on islet function in patients with latent autoimmune diabetes in adults].
3/2015	Response to comment on Liu et al. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3). Diabetes Care 2015;38:16-21.
1/2015	Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).
5/2014	Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study.
7/2013	Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus.
2/2013	Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yufei Xiang Research Topics

Disease

13	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2011
11	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 06/2011
9	Latent Autoimmune Diabetes in Adults 03/2016 - 02/2013
5	Neoplasms (Cancer) 01/2022 - 11/2011
4	Infections 02/2022 - 01/2021
3	COVID-19 03/2021 - 01/2020
3	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 12/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 08/2012
2	Weight Loss (Weight Reduction) 02/2021 - 01/2021
2	Viral Pneumonia 02/2021 - 01/2021
2	Insulin Resistance 01/2020 - 01/2019
2	Ketosis 01/2020 - 02/2013
2	Disease Progression 03/2015 - 01/2015
1	Diabetes Mellitus 01/2022
1	Obesity 11/2021
1	Melanoma (Melanoma, Malignant) 09/2021
1	Ovarian Neoplasms (Ovarian Cancer) 03/2021
1	Virus Diseases (Viral Diseases) 08/2020
1	Cytokine Release Syndrome 01/2020
1	Severe Acute Respiratory Syndrome 01/2020
1	Coronavirus Infections 01/2020
1	Cockayne Syndrome (Syndrome, Cockayne) 10/2018
1	Insulinoma 10/2012
1	Rheumatoid Arthritis 10/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2012
1	Glucose Intolerance 08/2012
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2008
1	Coronary Disease (Coronary Heart Disease) 01/2008
1	Vascular Diseases (Vascular Disease) 01/2008
1	ST Elevation Myocardial Infarction 01/2008

Drug/Important Bio-Agent (IBA)

10	AutoantibodiesIBA 01/2022 - 10/2012
7	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2022 - 10/2012
6	Insulin (Novolin)FDA Link 01/2022 - 02/2013
4	AntibodiesIBA 01/2022 - 12/2010
3	CytokinesIBA 09/2021 - 01/2020
3	C-PeptideIBA 01/2021 - 02/2013
2	VaccinesIBA 02/2022 - 01/2022
2	Zinc Transporter 8IBA 01/2022 - 07/2013
2	AerosolsIBA 02/2021 - 01/2021
2	C-Reactive ProteinIBA 01/2021 - 07/2011
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2020
2	AdiponectinIBA 01/2021 - 07/2011
2	HLA-DQ Antigens (HLA-DQ)IBA 01/2019 - 02/2013
2	Glucose (Dextrose)FDA LinkGeneric 03/2016 - 08/2012
1	EpitopesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	AlbuminsIBA 09/2021
1	Single-Domain AntibodiesIBA 03/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 03/2021
1	Cisplatin (Platino)FDA LinkGeneric 03/2021
1	MethyltransferasesIBA 03/2021
1	PlatinumIBA 03/2021
1	RNA (Ribonucleic Acid)IBA 03/2021
1	Lipocalin-2IBA 01/2021
1	Neutralizing AntibodiesIBA 08/2020
1	HDL CholesterolIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	IgA receptor (protein B)IBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	Sitagliptin Phosphate (Januvia)FDA Link 05/2014
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 05/2014
1	Dipeptidyl-Peptidase IV InhibitorsIBA 05/2014
1	Exenatide (Byetta)FDA Link 01/2013
1	ZincIBA 10/2012
1	Pharmaceutical PreparationsIBA 11/2011
1	ProdrugsIBA 11/2011
1	LigandsIBA 11/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2011
1	HLA-DQ8 antigenIBA 06/2011
1	Interleukin-10 (Interleukin 10)IBA 06/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2008
1	Troponin IIBA 01/2008

Therapy/Procedure

7	Therapeutics 11/2021 - 01/2008
1	Bariatric Surgery 11/2021